1. Home
  2. GEF vs IOVA Comparison

GEF vs IOVA Comparison

Compare GEF & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEF
  • IOVA
  • Stock Information
  • Founded
  • GEF 1877
  • IOVA 2007
  • Country
  • GEF United States
  • IOVA United States
  • Employees
  • GEF N/A
  • IOVA N/A
  • Industry
  • GEF
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GEF
  • IOVA Health Care
  • Exchange
  • GEF Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • GEF 4.0B
  • IOVA 975.1M
  • IPO Year
  • GEF N/A
  • IOVA N/A
  • Fundamental
  • Price
  • GEF $60.03
  • IOVA $2.22
  • Analyst Decision
  • GEF Hold
  • IOVA Buy
  • Analyst Count
  • GEF 4
  • IOVA 11
  • Target Price
  • GEF $71.50
  • IOVA $11.90
  • AVG Volume (30 Days)
  • GEF 242.4K
  • IOVA 9.5M
  • Earning Date
  • GEF 08-27-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • GEF 3.71%
  • IOVA N/A
  • EPS Growth
  • GEF N/A
  • IOVA N/A
  • EPS
  • GEF 4.00
  • IOVA N/A
  • Revenue
  • GEF $5,432,000,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • GEF N/A
  • IOVA $67.40
  • Revenue Next Year
  • GEF $12.31
  • IOVA $56.32
  • P/E Ratio
  • GEF $20.40
  • IOVA N/A
  • Revenue Growth
  • GEF 19.22
  • IOVA 636.99
  • 52 Week Low
  • GEF $48.23
  • IOVA $1.64
  • 52 Week High
  • GEF $73.16
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • GEF 33.57
  • IOVA 43.75
  • Support Level
  • GEF $59.65
  • IOVA $2.27
  • Resistance Level
  • GEF $62.06
  • IOVA $2.38
  • Average True Range (ATR)
  • GEF 1.62
  • IOVA 0.14
  • MACD
  • GEF -0.27
  • IOVA -0.01
  • Stochastic Oscillator
  • GEF 4.21
  • IOVA 28.21

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: